>AT1G07510.1 | ftsh10 (FtsH protease 10) ATP binding / ATPase/ metalloendopeptidase/ nucleoside-triphosphatase/ nucleotide binding / zinc ion binding
MIFSKLGSSLARSSRSKGFVYGGGVRSAVFNQGRLRAPQNLEAAVNQVDGGLGFLRRHFA
SFAARKGLEAGDLSRAFANPRLRRFFSSQTPKKKNYENYYPKDSKKAPKNEQKSESRDGS
KKNENENAGDAFSNEYQNMLIPLMAIALILSTFSLGSREQQQISFQEFKNKLLEAGLVDH
IDVSNKEVAKVYVRSSPKSQTTEEVVQGPGNGVPAKGRGGQYKYYFNIGSVESFEEKLEE
AQEAIGVNSHDFVPVTYVSETIWYQELLRFAPTLLLVATLIFGARRMQGGLGGLGGPGGK
AGRGIFNIGKAQITRADKNSKNKIYFKDVAGCEEAKQEIMEFVHFLQNPKKYEDLGAKIP
KGALLVGPPGTGKTLLAKATAGESAVPFLSISGSDFMEMFVGVGPSRVRNLFQEARQCAP
SIIFIDEIDAIGRARGRGGFSGGNDERESTLNQLLVEMDGFGTTAGVVVLAGTNRPDILD
KALLRPGRFDRQITIDKPDIKGRDQIFQIYLKKIKLDHEPSYYSQRLAALTPGFAGADIA
NVCNEAALIAARHEGATVTMAHFDSAIDRVIGGLEKKNRVISKLERRTVAYHESGHAVAG
WFLEHAEPLLKVTIVPRGTAALGFAQYVPNENLLMTKEQLFDMTCMTLGGRAAEQVLIGR
ISTGAQNDLEKVTKMTYAQVAVYGFSDKIGLLSFPQREDEFSKPYSNRTGAMIDEEVREW
VGKAYKRTVELIEEHKEQVAQIAELLLEKEVLHQDDLTKVLGERPFKSGETTNYDRFKSG
FEESEKESQKESVPVKPVEDDGIPPLEPQVVPT*
>AT1G03860.2 | ATPHB2 (PROHIBITIN 2)
MVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLGENYSE
RVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSITTLTFG
KEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANNQAFIT
LRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.2 | ATPHB2 (PROHIBITIN 2)
MVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLGENYSE
RVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSITTLTFG
KEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANNQAFIT
LRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.2 | ATPHB2 (PROHIBITIN 2)
MVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLGENYSE
RVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSITTLTFG
KEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANNQAFIT
LRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.1 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.1 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.1 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.3 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.3 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT1G03860.3 | ATPHB2 (PROHIBITIN 2)
MSFNKVPNIPGAPALSALLKVSVIGGLGVYALTNSLYNVDGGHRAVMFNRLTGIKEKVYP
EGTHFMVPWFERPIIYDVRARPYLVESTTGSHDLQMVKIGLRVLTRPMGDRLPQIYRTLG
ENYSERVLPSIIHETLKAVVAQYNASQLITQREAVSREIRKILTERASNFDIALDDVSIT
TLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDRRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIAQSANKVYLSSNDLLLNLQEMNLEPKK*
>AT2G29080.1 | ftsh3 (FtsH protease 3) ATP-dependent peptidase/ ATPase
MTMIFFSKLNRSISRSKGFLYGGGVRSAARLLTSPGLEAASVNEVEGGLGFIRRHFASLA
SRKGLVNNDLIGVFANPRLRRFFSDEAPKKKNYENYFPKDKQEPKSDQKSEHKEGSEKNE
NENVGDMFMNRFQNLLIPLLALAVFFSTFSFGSGEQQQISFQEFKNKLLEPGLVDHIDVS
NKSVAKVYVRSTPKDQQTTDVVHGNGNGIPAKRTGGQYKYYFNIGSVDSFEEKLEEAQEA
LGVDRHEYVPVTYVSEMVWYQEFMRFAPTLLLLGTLIYGARRMQGGLGVGGTGGKNGRGI
FNIGKATITRADKHSKNKIYFKDVAGCDEAKQEIMEFVHFLKNPKKYEDLGAKIPKGALL
VGPPGTGKTLLAKATAGESGVPFLSISGSDFMEMFVGVGPSRVRHLFQEARQAAPSIIFI
DEIDAIGRARGRGGLGGNDERESTLNQLLVEMDGFGTTAGVVVLAGTNRPDILDKALLRP
GRFDRQITIDKPDIKGRDQIFKIYLKKIKLDHEPSYYSQRLAALTPGFAGADIANVCNEA
ALIAARHEGATVTMAHFESAIDRVIGGLEKKNRVISKLERRTVAYHESGHAVVGWFLEHA
EPLLKVTIVPRGTAALGFAQYVPNENLLMTKEQLFDMTCMTLGGRAAEQVLIGKISTGAQ
NDLEKVTKMTYAQVAVYGFSDKVGLLSFPPRDDGYDFSKPYSNKTGAIIDEEVRDWVAKA
YERTVELVEEHKVKVAEIAELLLEKEVLHQDDLLKILGERPFKSAEVTNYDRFKSGFEET
EKDSAATPTVEPVVDDGAPPPFEPQVVPT*
>AT5G40770.1 | ATPHB3 (PROHIBITIN 3)
MGSQQAAVSFLSNLAKAAFGLGTAATVLNTSLFTVDGGERAVIFDRFRGVMDQTVGEGTH
FLIPILQRPHIFDIRTKPHTFSSISGTKDLQMVNLTLRVLSRPEVSRLPYIFQTLGLEYD
EKVLPSIGNEVLKAVVAQFNADQLLTERPHVSALVRESLITRAKDFNIVLDDVAITHLSY
GVEFSRAVEQKQVAQQEAERSKFVVMKADQERRAAVIRAEGESEAAQLISDATAKAGMGL
IELRRIEASREIASTLARSPNVAYLPGGQSMLFALNR*
>AT4G28510.1 | ATPHB1 (PROHIBITIN 1)
MNNVKVPKIPGGGAISTLLKVGIIGGLGLYGATHSLYNVEGGHRAIMFNRLVGIKDKVYP
EGTHLMIPWFERPVIYDVRARPYLVESTSGSRDLQMVKIGLRVLTRPMADQLPEIYRSLG
ENYSERVLPSIINETLKAVVAQYNASQLITQREAVSREIRKILTERAANFNVALDDVSIT
NLTFGKEFTAAIEAKQVAAQEAERAKFIVEKAEQDKRSAVIRAQGEAKSAQLIGQAIANN
QAFITLRKIEAAREIAQTIANSANKVYLSSDDLLLNLQGMNLDVDAKN*
>AT2G20530.1 | ATPHB6 (PROHIBITIN 6)
MNFKNVKVPKGPGGGVIAAVVIGGLSLYGATHTLYNVDGGHRAIVFNRLVGIKDKVYPEG
THLMIPWFERPIIYDVRAKPYLVESTSGSRDLQMVKIGLRVLTRPMADQLPEVYRSLGEN
YRERVLPSIIHETLKAVVAQYNASQLITQRESVSREIRKILTLRAANFHIALDDVSITGL
TFGKEFTAAIEGKQVAAQEAERAKFIVEKAEQDKRSAVIRAEGEAKSAQLIGQAIANNQA
FLTLRKIEAAREIAQTISRSANKVYLSSNDLLLNLQAMDLDVKPKK*
>AT2G20530.1 | ATPHB6 (PROHIBITIN 6)
MNFKNVKVPKGPGGGVIAAVVIGGLSLYGATHTLYNVDGGHRAIVFNRLVGIKDKVYPEG
THLMIPWFERPIIYDVRAKPYLVESTSGSRDLQMVKIGLRVLTRPMADQLPEVYRSLGEN
YRERVLPSIIHETLKAVVAQYNASQLITQRESVSREIRKILTLRAANFHIALDDVSITGL
TFGKEFTAAIEGKQVAAQEAERAKFIVEKAEQDKRSAVIRAEGEAKSAQLIGQAIANNQA
FLTLRKIEAAREIAQTISRSANKVYLSSNDLLLNLQAMDLDVKPKK*
>AT2G20530.2 | ATPHB6 (PROHIBITIN 6)
MNFKNVKVPKGPGGGVIAAVVIGGLSLYGATHTLYNVDGGHRAIVFNRLVGIKDKVYPEG
THLMIPWFERPIIYDVRAKPYLVESTSGSRDLQMVKIGLRVLTRPMADQLPEVYRSLGEN
YRERVLPSIIHETLKAVVAQYNASQLITQRESVSREIRKILTLRAANFHIALDDVSITGL
TFGKEFTAAIEGKQVAAQEAERAKFIVEKAEQDKRSAVIRAEGEAKSAQLIGQAIANNQA
FLTLRKIEAAREIAQTISRSANKVYLSSNDLLLNLQAMDLDVKPKK*
>AT2G20530.2 | ATPHB6 (PROHIBITIN 6)
MNFKNVKVPKGPGGGVIAAVVIGGLSLYGATHTLYNVDGGHRAIVFNRLVGIKDKVYPEG
THLMIPWFERPIIYDVRAKPYLVESTSGSRDLQMVKIGLRVLTRPMADQLPEVYRSLGEN
YRERVLPSIIHETLKAVVAQYNASQLITQRESVSREIRKILTLRAANFHIALDDVSITGL
TFGKEFTAAIEGKQVAAQEAERAKFIVEKAEQDKRSAVIRAEGEAKSAQLIGQAIANNQA
FLTLRKIEAAREIAQTISRSANKVYLSSNDLLLNLQAMDLDVKPKK*
>AT2G26140.1 | ftsh4 (FtsH protease 4) ATP-dependent peptidase/ ATPase/ metallopeptidase
MAWRRIITKVSSHERELSSLRSLLVRAYSSFPRVGVTGAVGGGGASLPRTRFQSSYVGSF
ARRVRDREEVNEVAHLRELIRRNDPEAVIRMFESQPSLHANASALSEYIKALVKVDRLDQ
SELVRTLQRGIAGVAREEETFGGLGAFRNVGKPTKDGVLGTASAPIHTISTERTHFKEQL
WSTIRTIGVGFLLISGIGALIEDRGIGKGLGLHEEVQPSMDSSTKFSDVKGVDEAKAELE
EIVHYLRDPKRFTRLGGKLPKGVLLVGPPGTGKTMLARAIAGEAGVPFFSCSGSEFEEMF
VGVGARRVRDLFSAAKKCSPCIIFIDEIDAIGGSRNPKDQQYMKMTLNQMLVELDGFKQN
EGIIVVAATNFPESLDKALVRPGRFDRHIVVPNPDVEGRRQILESHMSKVLKAEDVDLMI
IARGTPGFSGADLANLVNVAALKAAMDGSKDVTMSDLEFAKDRIMMGSERKSAVISDESR
KLTAFHEGGHALVAIHTEGALPVHKATIVPRGMALGMVSQLPDKDETSISRKQMLARLDV
CMGGRVAEELIFGESEVTSGASSDLEQATKLARAMVTKFGMSKEVGLVAHNYDDNGKSMS
TETRLLIESEVKQLLEKAYNNAKTILTVYNKELHALANALLQHETLSGKQIKELLTDLNS
PLLQKRQEVVTKQSNPVPPSTPSSASSAAAAAAAAAAAAAAAAATAATKGKDMAPVS*
>AT3G27280.2 | ATPHB4 (PROHIBITIN 4)
MGSQQVAISFLTNLAKAAFGLGVAATALNSSLYTVDGGERAVLFDRFRGVLDQTVGEGTH
FLIPYLQTPHIYDIRTKPHTFSSKSGTKDLQMVNLTLRVLFRPEVSRLPYIFQTLGLEYD
EKVLPSIGNEVLKAVVANFNADQLLTERPQVSALVRDALIKRAREFNIELDDIAITHLSY
GAEFSRAVEAKQVAQQEAERSKFVVMKADQERRAAVIRAEGESEAAQLISDATAKAGMGL
IELRRIEASREVAATLARSPNVAYLPGGQSMLFNLNPGR*
>AT3G27280.2 | ATPHB4 (PROHIBITIN 4)
MGSQQVAISFLTNLAKAAFGLGVAATALNSSLYTVDGGERAVLFDRFRGVLDQTVGEGTH
FLIPYLQTPHIYDIRTKPHTFSSKSGTKDLQMVNLTLRVLFRPEVSRLPYIFQTLGLEYD
EKVLPSIGNEVLKAVVANFNADQLLTERPQVSALVRDALIKRAREFNIELDDIAITHLSY
GAEFSRAVEAKQVAQQEAERSKFVVMKADQERRAAVIRAEGESEAAQLISDATAKAGMGL
IELRRIEASREVAATLARSPNVAYLPGGQSMLFNLNPGR*
>AT3G27280.1 | ATPHB4 (PROHIBITIN 4)
MGSQQVAISFLTNLAKAAFGLGVAATALNSSLYTVDGGERAVLFDRFRGVLDQTVGEGTH
FLIPYLQTPHIYDIRTKPHTFSSKSGTKDLQMVNLTLRVLFRPEVSRLPYIFQTLGLEYD
EKVLPSIGNEVLKAVVANFNADQLLTERPQVSALVRDALIKRAREFNIELDDIAITHLSY
GAEFSRAVEAKQVAQQEAERSKFVVMKADQERRAAVIRAEGESEAAQLISDATAKAGMGL
IELRRIEASREVAATLARSPNVAYLPGGQSMLFNLNPGR*
>AT3G27280.1 | ATPHB4 (PROHIBITIN 4)
MGSQQVAISFLTNLAKAAFGLGVAATALNSSLYTVDGGERAVLFDRFRGVLDQTVGEGTH
FLIPYLQTPHIYDIRTKPHTFSSKSGTKDLQMVNLTLRVLFRPEVSRLPYIFQTLGLEYD
EKVLPSIGNEVLKAVVANFNADQLLTERPQVSALVRDALIKRAREFNIELDDIAITHLSY
GAEFSRAVEAKQVAQQEAERSKFVVMKADQERRAAVIRAEGESEAAQLISDATAKAGMGL
IELRRIEASREVAATLARSPNVAYLPGGQSMLFNLNPGR*
>AT1G48030.1 | mtLPD1 (mitochondrial lipoamide dehydrogenase 1) ATP binding / dihydrolipoyl dehydrogenase
MAMASLARRKAYFLTRNLSNSPTDALRFSFSLSRGFASSGSDENDVVIIGGGPGGYVAAI
KASQLGLKTTCIEKRGALGGTCLNVGCIPSKALLHSSHMYHEAKHSFANHGIKVSSVEVD
LPAMLAQKDNAVKNLTRGIEGLFKKNKVTYVKGYGKFISPNEVSVETIDGGNTIVKGKHI
IVATGSDVKSLPGITIDEKKIVSSTGALSLSEVPKKLIVIGAGYIGLEMGSVWGRLGSEV
TVVEFAGDIVPSMDGEIRKQFQRSLEKQKMKFMLKTKVVSVDSSSDGVKLTVEPAEGGEQ
SILEADVVLVSAGRTPFTSGLDLEKIGVETDKAGRILVNDRFLSNVPGVYAIGDVIPGPM
LAHKAEEDGVACVEFIAGKHGHVDYDKVPGVVYTHPEVASVGKTEEQLKKEGVSYRVGKF
PFMANSRAKAIDNAEGLVKILADKETDKILGVHIMAPNAGELIHEAVLAINYDASSEDIA
RVCHAHPTMSEALKEAAMATYDKPIHI*
>AT1G48030.1 | mtLPD1 (mitochondrial lipoamide dehydrogenase 1) ATP binding / dihydrolipoyl dehydrogenase
MAMASLARRKAYFLTRNLSNSPTDALRFSFSLSRGFASSGSDENDVVIIGGGPGGYVAAI
KASQLGLKTTCIEKRGALGGTCLNVGCIPSKALLHSSHMYHEAKHSFANHGIKVSSVEVD
LPAMLAQKDNAVKNLTRGIEGLFKKNKVTYVKGYGKFISPNEVSVETIDGGNTIVKGKHI
IVATGSDVKSLPGITIDEKKIVSSTGALSLSEVPKKLIVIGAGYIGLEMGSVWGRLGSEV
TVVEFAGDIVPSMDGEIRKQFQRSLEKQKMKFMLKTKVVSVDSSSDGVKLTVEPAEGGEQ
SILEADVVLVSAGRTPFTSGLDLEKIGVETDKAGRILVNDRFLSNVPGVYAIGDVIPGPM
LAHKAEEDGVACVEFIAGKHGHVDYDKVPGVVYTHPEVASVGKTEEQLKKEGVSYRVGKF
PFMANSRAKAIDNAEGLVKILADKETDKILGVHIMAPNAGELIHEAVLAINYDASSEDIA
RVCHAHPTMSEALKEAAMATYDKPIHI*
>AT1G48030.2 | mtLPD1 (mitochondrial lipoamide dehydrogenase 1) ATP binding / dihydrolipoyl dehydrogenase
MAMASLARRKAYFLTRNLSNSPTDALRFSFSLSRGFASSGSDENDVVIIGGGPGGYVAAI
KASQLGLKTTCIEKRGALGGTCLNVGCIPSKALLHSSHMYHEAKHSFANHGIKVSSVEVD
LPAMLAQKDNAVKNLTRGIEGLFKKNKVTYVKGYGKFISPNEVSVETIDGGNTIVKGKHI
IVATGSDVKSLPGITIDEKKIVSSTGALSLSEVPKKLIVIGAGYIGLEMGSVWGRLGSEV
TVVEFAGDIVPSMDGEIRKQFQRSLEKQKMKFMLKTKVVSVDSSSDGVKLTVEPAEGGEQ
SILEADVVLVSAGRTPFTSGLDLEKIGVETDKAGRILVNDRFLSNVPGVYAIGDVIPGPM
LAHKAEEDGVACVEFIAGKHGHVDYDKVPGVVYTHPEVASVGKTEEQLKKEGVSYRVGKF
PFMANSRAKAIDNAEGLVKILADKETDKILGVHIMAPNAGELIHEAVLAINYDASSEDIA
RVCHAHPTMSEALKEAAMATYDKPIHI*
>AT1G48030.2 | mtLPD1 (mitochondrial lipoamide dehydrogenase 1) ATP binding / dihydrolipoyl dehydrogenase
MAMASLARRKAYFLTRNLSNSPTDALRFSFSLSRGFASSGSDENDVVIIGGGPGGYVAAI
KASQLGLKTTCIEKRGALGGTCLNVGCIPSKALLHSSHMYHEAKHSFANHGIKVSSVEVD
LPAMLAQKDNAVKNLTRGIEGLFKKNKVTYVKGYGKFISPNEVSVETIDGGNTIVKGKHI
IVATGSDVKSLPGITIDEKKIVSSTGALSLSEVPKKLIVIGAGYIGLEMGSVWGRLGSEV
TVVEFAGDIVPSMDGEIRKQFQRSLEKQKMKFMLKTKVVSVDSSSDGVKLTVEPAEGGEQ
SILEADVVLVSAGRTPFTSGLDLEKIGVETDKAGRILVNDRFLSNVPGVYAIGDVIPGPM
LAHKAEEDGVACVEFIAGKHGHVDYDKVPGVVYTHPEVASVGKTEEQLKKEGVSYRVGKF
PFMANSRAKAIDNAEGLVKILADKETDKILGVHIMAPNAGELIHEAVLAINYDASSEDIA
RVCHAHPTMSEALKEAAMATYDKPIHI*
>AT3G10050.1 | OMR1 (L-O-METHYLTHREONINE RESISTANT 1) L-threonine ammonia-lyase
MNSVQLPTAQSSLRSHIHRPSKPVVGFTHFSSRSRIAVAVLSRDETSMTPPPPKLPLPRL
KVSPNSLQYPAGYLGAVPERTNEAENGSIAEAMEYLTNILSTKVYDIAIESPLQLAKKLS
KRLGVRMYLKREDLQPVFSFKLRGAYNMMVKLPADQLAKGVICSSAGNHAQGVALSASKL
GCTAVIVMPVTTPEIKWQAVENLGATVVLFGDSYDQAQAHAKIRAEEEGLTFIPPFDHPD
VIAGQGTVGMEITRQAKGPLHAIFVPVGGGGLIAGIAAYVKRVSPEVKIIGVEPADANAM
ALSLHHGERVILDQVGGFADGVAVKEVGEETFRISRNLMDGVVLVTRDAICASIKDMFEE
KRNILEPAGALALAGAEAYCKYYGLKDVNVVAITSGANMNFDKLRIVTELANVGRQQEAV
LATLMPEKPGSFKQFCELVGPMNISEFKYRCSSEKEAVVLYSVGVHTAGELKALQKRMES
SQLKTVNLTTSDLVKDHLRYLMGGRSTVGDEVLCRFTFPERPGALMNFLDSFSPRWNITL
FHYRGQGETGANVLVGIQVPEQEMEEFKNRAKALGYDYFLVSDDDYFKLLMH*
>AT3G05780.1 | LON3 (LON PROTEASE 3) ATP binding / ATP-dependent peptidase/ nucleoside-triphosphatase/ nucleotide binding / serine-type endopeptidase/ serine-type peptidase
MMPKRFNTSGFDTTLRLPSYYGFLHLTQSLTLNSRVFYGARHVTPPAIRIGSNPVQSLLL
FRAPTQLTGWNRSSRDLLGRRVSFSDRSDGVDLLSSSPILSTNPNLDDSLTVIALPLPHK
PLIPGFYMPIHVKDPKVLAALQESTRQQSPYVGAFLLKDCASTDSSSRSETEDNVVEKFK
VKGKPKKKRRKELLNRIHQVGTLAQISSIQGEQVILVGRRRLIIEEMVSEDPLTVRVDHL
KDKPYDKDNAVIKASYVEVISTLREVLKTNSLWRDQDIGDFSYQHLADFGAGISGANKHK
NQGVLTELDVHKRLELTLELVKKQVEINKIKETDDGSSLSAKIRVRIDTKRDKIPKHVIK
VMEEEFTKLEMLEENYSDFDLTYNYLHWLTVLPWGNFSYENFDVLRAKKILDEDHYGLSD
VKERILEFIAVGRLRGTSQGKIICLSGPPGVGKTSIGRSIARALDRKFFRFSVGGLSDVA
EIKGHCQTYVGAMPGKMVQCLKSVGTANPLILFDEIDKLGRCHTGDPASALLEVMDPEQN
AKFLDHFLNVTIDLSKVLFVCTANVIEMIPGPLLDRMEVIDLSGYVTDEKMHIARDYLVK
KTCRDCGIKPEHVDLSDAALLSLIENYCREAGVRNLQKQIEKIYRKVALELVRQGAVSFD
VTDTKDTKSLAKTDSEVKRMKVADIMKILESATGDSTESKTKQSGLVAKTFEKVMIDESN
LADYVGKPVFQEEKIYEQTPVGVVMGLAWTSMGGSTLYIETTFVEEGLGKGGLHITGQLG
DVMKESAQIAHTVARRIMFEKEPENLFFANSKLHLHVPEGATPKDGPSAGCTMITSFLSL
AMKKLVRKDLAMTGEVTLTGRILPIGGVKEKTIAARRSQIKTIIFPEANRRDFEELAENM
KEGLDVHFVDEYEKIFDLAFNYDH*
>AT5G26860.1 | LON1 (LON PROTEASE 1) ATP binding / ATP-dependent peptidase/ serine-type peptidase
MKGFDTNLRLQASSPEFSNGFLPKRQNFIKLNRRNCYPRSSFSPTMLKLFTSSASRVHHL
TPVSRVVGSSPVESPLFKALSQITGWNRRSTSLGHRAFFCSEPTNGEAAAEAETKAVESD
SEVSDSKSSSAIVPTNPRPEDCLTVLALPVPHRPLFPGFYMPIYVKDPKVLAALQESRRR
QAPYAGAFLLKDDPSADSSSSTDAEKNINELKGKELLNRLHEVGTLAQISSIQGDQVILV
GHRRLRIKEMVSEEPLTVKVDHLKDNPFDMDDDVVKATSFEVISTLRDVLKTSSLWRDHV
QTYTQHIGDFTYPRLADFGAAICGANRHQAQEVLEELDVHKRLRLTLELMKKEMEISKIQ
ETIAKAIEEKISGEQRRYLLNEQLKAIKKELGVETDDKSALSAKFKERIEPNKEKIPAHV
LQVIEEELTKLQLLEASSSEFNVTRNYLDWLTILPWGNYSNENFDVARAQTILDEDHYGL
SDVKERILEFIAVGRLRGTSQGKIICLSGPPGVGKTSIGRSIARALNRKFFRFSVGGLAD
VAEIKGHRRTYVGAMPGKMVQCLKSVGTANPLVLIDEIDKLGRGHAGDPASALLELLDPE
QNANFLDHYLDVTIDLSKVLFVCTANVIDMIPNPLLDRMEVISIAGYITDEKVHIARDYL
EKTARGDCGVKPEQVEVSDAALLSLIENYCREAGVRNLQKQIEKIYRKIALKLVREGAVP
EEPAVASDPEEAEIVADVGESIENHTVEENTVSSAEEPKEEAQTEKIAIETVMIDESNLA
DYVGKPVFHAEKLYEQTPVGVVMGLAWTSMGGSTLYIETTVVEEGEGKGGLNITGQLGDV
MKESAQIAHTVARKIMLEKEPENQFFANSKLHLHVPAGATPKDGPSAGCTMITSLLSLAT
KKPVRKDLAMTGEVTLTGRILPIGGVKEKTIAARRSQIKTIIFPEANRRDFDELAENVKE
GLNVHFVDDYGKIFELAFGYDKQED*
>AT2G19670.1 | PRMT1A (PROTEIN ARGININE METHYLTRANSFERASE 1A) protein-arginine N-methyltransferase
MTSTENNNNGSDETQTTKLHFEDADESMHDGDDNNADVADDITSADYYFDSYSHFGIHEE
MLKDVVRTKSYQDVIYKNKFLIKDKIVLDVGAGTGILSLFCAKAGAAHVYAVECSQMADT
AKEIVKSNGFSDVITVLKGKIEEIELPVPKVDVIISEWMGYFLLYENMLDTVLYARNKWL
VDGGIVLPDKASLYVTAIEDAHYKDDKVEFWDDVYGFDMSCIKRRAITEPLVDTVDGNQI
VTDSKLLKTMDISKMAAGDASFTAPFKLVAQRNDHIHALVAYFDVSFTMCHKKMGFSTGP
KSRATHWKQTVLYLEDVLTICEGETITGSMTIAQNKKNPRDVDIKLSYSLNGQHCNISRT
HFYKMR*
>AT2G46470.1 | OXA1L (INNER MEMBRANE PROTEIN OXA1-LIKE)
MATCLRGITKRVNLLQRRVYPSCGHLIRDDRDETKSGSSDTMIREVLARNGTNKLSSMFA
DRHYQSFATGPLGLGLSSCRHMSSTPPEWSDKVDGIDFVATEVVPDEIIEAVTTTSQAVV
PAINEVAIAAADSAFPVAALQHLIDAVHSFTGLNWWASIALTTVLIRGVTIPILLNQLKA
TYKLNVLRPQLEELRQEMSTKAQDPEAMAEGQRRMQLLFKEHGVTPFTPLKGLIIQGPIF
ISFFFAIRNMAEKVPSFKTGGTLWFTDLTTTDTTYILPLLTAVTFLIMVESNMQEGLEGN
PVAGTMKKFSRIIAFLSIPVLIGIEKALFCYWLTSNLFTLVYGLTLRRPDVRKLLNLPDV
VNSSTRQPSPSSPLPFSFAEPKDQSVVAQEKPPMSSESSSSVPDRRISRSSVLNQRIRTL
ERQLKDRKIKK*
>AT1G64520.1 | RPN12a (Regulatory Particle non-ATPase 12a) peptidase
MDPQLTEVSQQFERFKAAFARKDYNTCSDLLSQLKVLLTKFTSLPPLFENSPNAAKELTI
ARDIYEHAVVLSVKTEDQDAFERDFFQLKPYYVDARNRIPQSPQENLILGLNLLRLLVQN
RIAEFHTELELLSSATLEDPCIKHAVELEQSFMEGAYNRVLSARQTAPDATYVYFMDLLA
KTIRDEIAGCSEKAYDYVSISDARQMLLFSSDQELLTYVTDEHPEWEVKEGFVVFQKAKE
TAPCKEIPSLQLINQTLSYARELERIV*
>AT1G73570.1 | suppressor of lin-12-like protein-related / sel-1 protein-related
MRVSGQSIIAISLFTLSLYIHRVQARPFVLVLSNEDLNGGFNDNGAYESSDFDEFGESEP
KSEEELDPGSWRRIFETNESTVHASASPQYYSGLHKILSAASEGNTTLMEEAVSEIDSSA
SSGDPHAQSVMGFVYGIGMMRETSRSKSILHHHFAAAGGNMQSKMALAFRYLRQNMYDKA
VELYAELAETAVNSFLISKDSPMAEPVRIHIGTEENKDALRKSRGEEDEDFQILEYQAEK
GNSVAMHKIGLFYYFGLRGLRRDHAKALYWFSKAEFNGLGYLYVKGYGVDKRNYTKAREY
FEMAANNEDPSGHYNLGVLYLKGTGVKKDVRHATKYFFVAANAGQPKAFYQLAKMFHTGV
GLTKNLEMATTFYKLVAERGPWSSLSRWALEAYLKGDVGKAFILYSRMSELGYEVAQSNA
AWIVDKYGERSMCMGVYGFCTDKERHDRAHSLWWRASEQGNEHAALLIGDAYYYGRGTER
DFVRAAEAYMYAKSQSNAQAMFNLGYMHEHGEGLPFDLHLAKRYYDQALQSDTAAKLPVT
LALASVWVRRNYADTALVQVLNSLPEVHQKVVEWVENGMLEEVVLDPVGANVAQPLAAPV
AFPQ*
>AT2G17280.1 | phosphoglycerate/bisphosphoglycerate mutase family protein
MDNEGIGLYPLHRCKTIHLVRHAQGIHNVAGEKDHSAYSSEDYFDAHLTPLGWQQVDNLR
NHVRAAQLLNKVELVIVSPMLRTIQTAVGAFGGEEDTNGADATPLMVANAGSSDRPAISS
LNSPPFLAVELCRETMGDHPCDRRRSVTEYKALFPAIDFSIIETDNDVLWKPSPRESLEE
VAARGVEFIKWIWTRKEKEIAIVSHSGFLHGLLSSFGKDCCDDLKKELSIHLSNCELRSM
VIVDRGNLGTDSAETTNYPGKVPEGLDNPSG*
>AT2G17280.1 | phosphoglycerate/bisphosphoglycerate mutase family protein
MDNEGIGLYPLHRCKTIHLVRHAQGIHNVAGEKDHSAYSSEDYFDAHLTPLGWQQVDNLR
NHVRAAQLLNKVELVIVSPMLRTIQTAVGAFGGEEDTNGADATPLMVANAGSSDRPAISS
LNSPPFLAVELCRETMGDHPCDRRRSVTEYKALFPAIDFSIIETDNDVLWKPSPRESLEE
VAARGVEFIKWIWTRKEKEIAIVSHSGFLHGLLSSFGKDCCDDLKKELSIHLSNCELRSM
VIVDRGNLGTDSAETTNYPGKVPEGLDNPSG*
>AT2G17280.2 | phosphoglycerate/bisphosphoglycerate mutase family protein
MDNEGIGLYPLHRCKTIHLVRHAQGIHNVAGEKDHSAYSSEDYFDAHLTPLGWQQVDNLR
NHVRAAQLLNKVELVIVSPMLRTIQTAVGAFGGEEDTNGADATPLMVANAGSSDRPAISS
LNSPPFLAVELCRETMGDHPCDRRRSVTEYKALFPAIDFSIIETDNDVLWKPSPRESLEE
VAARGVEFIKWIWTRKEKEIAIVSHSGFLHGLLSSFGKDCCDDLKKELSIHLSNCELRSM
VIVDRGNLGTDSAETTNYPGKVPEGLDNPSG*
>AT2G17280.2 | phosphoglycerate/bisphosphoglycerate mutase family protein
MDNEGIGLYPLHRCKTIHLVRHAQGIHNVAGEKDHSAYSSEDYFDAHLTPLGWQQVDNLR
NHVRAAQLLNKVELVIVSPMLRTIQTAVGAFGGEEDTNGADATPLMVANAGSSDRPAISS
LNSPPFLAVELCRETMGDHPCDRRRSVTEYKALFPAIDFSIIETDNDVLWKPSPRESLEE
VAARGVEFIKWIWTRKEKEIAIVSHSGFLHGLLSSFGKDCCDDLKKELSIHLSNCELRSM
VIVDRGNLGTDSAETTNYPGKVPEGLDNPSG*
>AT2G43790.1 | ATMPK6 (ARABIDOPSIS THALIANA MAP KINASE 6) MAP kinase/ kinase
MDGGSGQPAADTEMTEAPGGFPAAAPSPQMPGIENIPATLSHGGRFIQYNIFGNIFEVTA
KYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIANAFDNKIDAKRTLREIKLLRHMDHE
NIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI
HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLLNSSD
YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAKRYIR
QLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISDEPEC
TIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ*
>AT1G78770.1 | cell division cycle family protein
MREEEIEKIRGVVRDCVSKHLYSSAIFFADKVAALTNDPSDIYMQAQALFLGRHYRRAFH
LLNASKIVLRDLRFRYLAAKCLEELKEWDQCLLMLGDAKVDDDGIVYDAKDGNVIDFDKD
GEDREINISSAICFLRGKAYGALQNRSQARQWYKAAIKADPLCYEALECLIESHMLTSEE
ESSLLSSLQFSPEDGWLSSFYSCLIKKYDKESTVELKFKKLENETSGSVSGSSMITLANN
TDLLACKAEYYHQCCEYQKCFELTAALLEKDPFHLKCTLVHLAAAMELGNSNELYLMACN
LVKDYPSKALSWFAVGCYYYCIKKYAEARRYFSKATGIDGSFSPARIGYGNSFAAQEEGD
QAMSAYRTAARLFPGCHLPTLYIGMEYMRTHSYKLADQFFMQAKAICPSDPLVYNELGVV
AYHMKEYGKAVRWFEKTLAHIPSALTESWEPTVVNLAHAYRKLRKDREAISYYERALTLS
TKSLSTYSGLAYTYHLQGNFSAAISYYHKALWLKPDDQFCTEMLNVALMDECQNGVDSKV
ELC*
>AT1G31660.1 | FUNCTIONS IN molecular_function unknown INVOLVED IN biological_process unknown LOCATED IN cellular_component unknown EXPRESSED IN 21 plant structures EXPRESSED DURING 13 growth stages CONTAINS InterPro DOMAIN/s Bystin (InterProIPR007955) Has 370 Blast hits to 362 proteins in 156 species Archae - 0 Bacteria - 7 Metazoa - 139 Fungi - 93 Plants - 32 Viruses - 0 Other Eukaryotes - 99 (source NCBI BLink)
MAKKRDRIVNTQPFISDDASVASSRKRSKVPKTHQKQEKLIEAGMSEKIMKQALAQQKEV
ADEENAERNPSSAAFAVAGAATAGEEQKILEEEEDDIDDFDGTFENQSQFDKQEEINEDD
EKLFESFLNKNAPPQRTLTDIIIKKLKDKDADLAEEERPDPKMDPAITKLYKGVGKFMSE
YTVGKLPKAFKLVTSMEHWEDVLYLTEPEKWSPNALYQATRIFASNLKDRQVQRFYNYVL
LPRVREDIRKHKKLHFALYQALKKSLYKPSAFNQGILFPLCKSGTCNLREAVIIGSILEK
CSIPMLHSCVALNRLAEMDYCGTTSYFIKVLLEKKYCMPYRVLDALVAHFMRFVDDIRVM
PVIWHQSLLTFVQRYKYEILKEDKEHLQTLLQRQKHHLVTPEILRELKDSRNRGEKEDPM
VDNFAPVPAKEDRFDIPEVPMEED*
>AT5G51740.1 | peptidase M48 family protein
MSWYRRTKLVFDSLRRNINPKILPRSHVTSRINNPIGSSNPSAKFSSISSREVGLRSWTS
LGRNTNRIAYNPFLSQPKRYYYVDRYQVRHFKPRGPGRWFQNPRTVFTVVLVGSVGLITL
IVGNTETIPYTKRTHFILLSKPMEKLLGETQFEQIKKTYQGKILPATHPESIRVRLIAKE
VIDALQRGLSNERVWSDLGYASTESSLGGGSDKGVKEMEMAMSGEDTMTDMKWSKEDQVL
DDQWIQKSRKKDSKAHAATSHLEGISWEVLVVNEPIVNAFCLPAGKIVVFTGLLNHFKSD
AEVATVIGHEVGHAVARHVAEGITKNLWFAILQLVLYQFVMPDLVNTMSALFLRLPFSRK
MEIEADYIGLLLLASAGYDPRVAPTVYEKLGKLGGDALGDYLSTHPSGKKRSKLLAQANV
MEEALMIYREVQAGRTGVEGFL*
>AT5G13780.1 | GCN5-related N-acetyltransferase putative
MVCIRRATVDDLLAMQACNLMCLPENYQMKYYLYHILSWPQLLYVAEDYNGRIVGYVLAK
MEEESNECHGHITSLAVLRTHRKLGLATKLMTAAQAAMEQVYEAEYVSLHVRRSNRAAFN
LYTETLGYKINDVEAKYYADGEDAYDMRKNLKGKQNHHHAHGHHHHHGGGCCSGDAKVVE
TAQAVDGKAVSK*
>AT1G80410.1 | EMB2753 (EMBRYO DEFECTIVE 2753) binding
MGASLPPKEANLFKLIVKSYETKQYKKGLKAADAILKKFPDHGETLSMKGLTLNCMDRKT
EAYELVRLGVKNDIKSHVCWHVLGLLYRSDREYREAIKCYRNALRIDPDNLEILRDLSLL
QAQMRDLSGFVETRQQLLTLKPNHRMNWIGFAVSQHLNANASKAVEILEAYEGTLEDDYP
PENELIEHTEMILYKVSLLEESGSFDKALEELHKKEPKIVDKLSYKEQEVSLLSKVGRLE
EANKLYRVLLSMNPDNYRYHEGLQKCLGLYSESGQYSSDQIEKLNALYQSLSEQYTRSSA
VKRIPLDFLQDENFKEAVAKYIKPLLTKGVPSLFSDLSSLYDHPRKPDILEQLVVEMKHS
IGTTGSFPGSDVKEPPSTLLWTLFFLAQHYDRRGQYDVALCKIDEAIAHTPTVIDLYSVK
SRIMKHAGDLTAAAALADEARGMDLADRYINSECVKRMLQADQVPLAEKTAVLFTKEGDQ
LNNLHDMQCMWYDLASGDSYFRQGDLGRALKKFLAVEKHYADISEDQFDFHSYCLRKMTL
RSYVDMLKFQDRLHSFPYFHKAAIRAIRCYLKLHDSPKSTAGEDEMSKLAPAQKKKIKKQ
KKAEARAKKEAESKSEESTASGASKSGKRNVKPVDPDPHGQKLIQVEEPMAEASKYLRLL
QKHSPNSLETHLLSFEVNMRKQKFLLAFQAVKQLLKLGAENPDSHRSLVKFFLMTESISA
PTTEAEKLRWRVLEAERPSISQLQNKSLMEANKEFLGRHEDSLVHRAAYAEMLYILDPSK
KTEAIKIIEDSTNKVVQTNEALGQAREWKLKDCIAVHTLLDTVLLDSQAASRWKSRCAEY
FPCSTHFEGKHCSLMPDSVYNSSRKSNENGDTPNHPMGQTELSDGQLEAFKSLSVAT*
Your search returns no results, please check if everything was correct, and feel free to resubmit your search